through expertise and experience
The 2023 ACRO survey of over 6,000 clinical trials showed that operationalizing RBQM is an industry-wide challenge.
While over 97% of new studies conduct an initial risk assessment, and conduct ongoing risk evaluations, less than 50% have Key Risk Indicators (KRIs) related to data quality or patient safety, and only 42% have centralized monitoring. That demonstrates the size of the problem in moving from the risk assessment to implementing other RBQM components.
We can help with that. From the experience of implementing RBQM solutions on hundreds of trials, we've developed a set of consultancy services and tools to accelerate your RBQM initiatives.
Resistance to change is often cited as the biggest blocker to RBQM success. So, how do you take hearts and minds with you on your RBQM journey? Simple. With our proven 4-step model. Proven because we've used it to drive significant change in global organizations, with lasting results including increased revenues, more efficient trials, and happier staff.